Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depresssive disorder

Molecular Psychiatry

Volumn 5, Issue 2, 2000, Pages 142-149

  Johnston Wilson, N L ^a,e   Sims, C D ^b   Hofmann, J P ^b   Anderson, L ^b   Shore, A D ^c   Torrey, E F ^d   Yolken, R H ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Large Scale Biology Corporation   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Stanley Foundation   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carbonic anhydrase I; Dihydropyrimidinase related protein 2; Fructose bisphosphate aldolase C; Glial acidic fibrillary acidic protein; Postmortem human brain; Two dimensional gel electrophoresis; Ubiquinol cytochrome c reductase complex core protein 1

Indexed keywords

BRAIN PROTEIN; CARBONATE DEHYDRATASE; CORE PROTEIN; DIHYDROPYRIMIDINASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GLIAL FIBRILLARY ACIDIC PROTEIN; UBIQUINOL CYTOCHROME C REDUCTASE;

AMINO ACID SEQUENCE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DEPRESSION; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MANIC DEPRESSIVE PSYCHOSIS; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SCHIZOPHRENIA; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 0034054736     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000696     Document Type: Article

References (44)

1. 1 O'Farrell P. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975; 250: 4007-4021.
2. 2 Comings DE. Two-dimensional gel electrophoresis of human brain proteins. III Genetic and non-genetic variations in 145 brains. Clin Chem 1982; 28: 798-804.
3. 3 Edgar PF, Schonberger SJ, Dean B, Faull RLM, Kydd R, Cooper GJS. A comparative proteome analysis of hippocampal tissue from schizophrenia and Alzheimer's disease individuals. Mol Psychiatry 1999; 4: 173-178.
4. 4 Harrington M, Merril CR, Torrey EF. Differences in cerebrospinal fluid proteins between patients with schizophrenia and normal persons. Clin Chem 1985; 31: 722-726.
5. 5 Merril CR, Harrington MG. Use of two-dimensional electrophoretic protein maps in studies of schizophrenia. Schizophr Bull 1988; 14: 249-254.
6. 6 Wildenauer DB, Korschenhausen D, Hoechtlen W, Ackenheil M, Kehl M, Lottspeich F. Analysis of cerebrospinal fluid from patients with psychiatric and neurological disorders by two-dimensional electrophoresis: identification of disease associated polypeptides as filbrin fragments. Electrophoresis 1991; 12: 487-492.
7. 7 Johnson G, Brane D, Block W, van Kammen DP, Gurklis J, Peters JL et al. Cerebrospinal fluid protein variations in common to Alzheimer's disease and schizophrenia. Appl Theo Electrophor 1992; 3: 47-53.
8. 8 James P. Of genomes and proteomes. Biochem Biphys Res Comm 1997; 231: 1-6.
9. 9 Shevchenko A, Jensen ON, Podtelejnikov AV, Sagliocco F, Wilm M, Vorm O et al. Linking genome and proteome by mass spectrometry: large scale identification of yeast proteins from two-dimensional gels. Proc Natl Acad Sci USA 1996; 93: 14440-14445.
10. 10 Anderson NL, Esquer-Blasco R, Hofmann J-P, Meheus L, Raymackers J, Steiner S et al. An updated two-dimensional gel database of rat liver proteins useful in gene regulation and drug effects studies. Electrophoresis 1995; 16: 1977-1981.
11. 11 Johnston NL, Cervenak J, Shore D, Torrey EF, Yolken RH, the Stanley Neuropathology Consortium. Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. J Neurosci Meth 1997; 77: 83-92.
12. 12 Goshima Y, Nakamura F, Strittmatter P, Strittmatter SM. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 1995; 376: 509-514.
13. 13 Goshima Y, Kawakami T, Hori H, Sugiyama Y, Takasawa S, Hashimotn Y et al. A novel action of collapsin: collapsin-1 increases antereo- and retrograde axoplasmic transport independently of growth cone collapse. J Neurobiol 1997; 33: 316-328.
14. 14 Wang L-H, Strittmatter SM. A family of rat CRMP genes is differentially expressed in the nervous system. J Neurosci 1996; 16: 6197-6207.
15. 15 Hamajima N, Matsuda K, Sakata S, Tamaki N, Sasaki M, Nonaka M. A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene 1996; 180: 157-163.
16. 16 Putman CW, Rotteveel JJ, Wevers RA, van Gennip AH, Bakkeren JA, De Abreu RA. Dihydropyrimidinase deficiency, a progressive neurological disorder? Neuropediatrics 1997; 28: 106-110.
17. 17 Henderson MJ, Ward K, Simmonds HA, Duley JA, Davies PM. Dihydropyrimidinase deficiency presenting in infancy with severe developmental delay. J Inherit Metab Dis 1993; 16: 574-576.
18. 18 Hayes SG. Azetazolamide in bipolar affective disorders. Ann Clin Psych 1994; 6: 91-98.
19. 19 Giacobni E. A cytochemical study of the localization of carbonic anhydrase in the nervous system. J Neurochem 1962; 9: 169-177.
20. 20 Roussel G, Delaunoy JP, Nussbaum JL, Mandel P. Demonstration of a specific localization of carbonic anhydrase C in the glial cells of rat CNS by an immunohistochemical method. Brain Res 1979; 160: 47-55.
21. 21 Chesler M, Kaila K. Modulation of pH by neuronal activity. TINS 1992; 15: 396-402.
22. 22 Wilson VJG, Graham JG, McQueen INF, Thompson RJ. Immunoreactive aldolase C in cerebrospinal fluid of patients with neurological disorders. Ann Clin Biochem 1980; 17: 110-113.
23. 23 Meltzer H. Creative kinase and aldolase in serum: abnormality common to acute psychoses. Science 1968; 159: 1368-1370.
24. 24 Meltzer H. Increased activity of creatine phosphokinase and aldolase activity in the acute psychoses: case report. J Psychiat Res 1970; 7: 249-262.
25. 25 Coffey JW, Heath RG, Guschwan AF. Serum creatine kinase, aldolase, and copper in acute and chronic schizophrenics. Biol Psych 1970; 2: 331-339.
26. 26 Meltzer HY, Grinspoon L, Shader RI. Serum creatine phophokinase and aldolase activity in acute schizophrenic patients and their relatives. Compr Psychiatry 1970; 11: 552-558.
27. 27 Pol S, Bousquet-Lemercier B, Pave-Preux M, Pawlak A, Nalpas B, Berthelot P et al. Nucleotide sequence and tissue distribution of the human mitochondrial aspartate aminotransferase mRNA. Biochem Biophys Res Commun 1988; 157: 1309-1315.
28. 28 Mulcrone J, Whatley SA, Ferrier IN, Marchbanks R. A study of altered gene expression in frontal cortex from schizophrenic patients using differential screening. Schizophr Res 1995; 14: 203-213.
29. 29 Bigbee JW, Eng LF. Analysis and comparison of in vitro synthesized glial fibrillary acidic protein with rat CNS intermediate filament proteins. J Neurochem 1982; 38: 130-134.
30. 30 Ishida K, Kaneko K, Kubota T, Itoh Y, Miyatake T, Matsushita M et al. Identification and characterization of an anti-glial fibrillary acidic protein antibody with a unique specificity in a demented patient with an autoimmune disorder. J Neurol Sci 1997; 151: 41-48.
31. 31 Fujita K, Yamanchi M, Matsui T, Titani K, Takahashi H, Kato T et al. Increase of glial fibrillary acidic protein fragments in the spinal cord of motor neuron degeneration mutant mouse. Brain Res 1998; 785: 31-40.
32. 32 Laping NJ, Nichols NR, Day JR, Johnson SA, Finch CE. Transcriptional control of glial fibrillary acidic protein and glutamine synthetase in vivo shows opposite responses to corticosterone in the hippocampus. Endocrinology 1994; 135: 1928-1933.
33. 33 Norton WT, Aquino DA, Hozumi I, Chui F-C, Brosnan CF. Quantitative aspects of reactive gliosis: a review. Neurochem Res 1992; 17: 877-885.
34. 34 Tardy M, Fages C, LePrince G, Rolland B, Nunez J. Regulation of the glial fibrillary acidic protein (GFAP) and of its encoding mRNA in the developing brain and in cultured astrocytes. Mol Aspects Dev Aging Nerv Syst 1990; 265: 41-52.
35. 35 Inagaki M, Gonda Y, Nishizawa K, Kitamura S, Sato C, Ando S et al. Phosphorylation sites linked to glial filament disassembly in vitro locate in a non-alpha-helical head domain. J Biol Chem 1990; 265: 4722-4729.
36. 36 Inagaki M, Nakamura Y, Masatoshi T, NishimuraT, Inagaki N. Glial fibrillary acidic protein: dynamic property and regulation by phosphorylation. Brain Pathol 1994; 4: 239-243.
37. 37 Perrone-Bizzozero NI, Sower AC, Bird ED, Benowitz LI, Ivins KJ, Neve RL. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci USA 1996; 93: 14182-14187.
38. 38 Eng L, Ghirnikar RS. GFAP and astrogliosis. Brain Pathol 1994; 4: 229-237.
39. 39 Goodison KL, Parhad IM, White CL III, Sima AF, Clark AW. Neuronal and glial gene expression in neocortex of Down's Syndrome and Alzheimer's Disease. J Neuropath Exp Neuro 1993; 52: 192-198.
40. 40 Murphy GM Jr. Lee YL, Jia XC, Yu AC, Majewska A, Song Y et al. Tumor necrosis factor-α and basic fibroblast growth factor decrease glial fibrillary acidic protein and its encoding mRNA in astrocyte cultures and glioblastoma cells. J Neurochem 1995; 65: 2716-2714.
41. 41 Rinaman L, Card JP, Enquist LW. Spatiotemporal responses of astrocytes, ramified microglia, and brain macrophages to central neuronal infection with pseudorabies virus. J Neurosci 1993; 13: 687-700.
42. 42 Kennedy PG, Ajor EO, Williams RK, Straus SE. Down-regulation of glial fibrillary acidic protein expression during acute lytic varicella-zoster virus infection of cultured human astrocytes. Virology 1994; 205: 558-562.
43. 43 Pulliam L, West D, Haigwood N, Swanson RA. HIV-1 envelope gp120 alters astrocytes in human brain cultures. AIDS Res Hum Retroviruses 1993; 9: 439-444.
44. 44 Levi G, Patrizio M, Bernardo A, Petrucci TC, Agresti C. Human immunodeficiency virus coat protein gp120 inhibits the β-adrenergic regulation of astroglial and microglial functions. Proc Natl Acad Sci USA 1993; 90: 1541-1545.